StonvexLoading…
StonvexStonvexStonvexCore line items from BZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.18B | $1.01B | $838.33M | $654.04M |
Operating Income | $352.36M | $160.69M | $81.83M | $-18.78M |
Net Income | $391.15M | $1.58B | $1.10B | $15.55M |
EPS (Diluted) | $0.42 | $0.24 | $0.17 | $0.02 |
Total Assets | $3.51B | $2.65B | $2.53B | $2.15B |
Total Liabilities | $641.63M | $595.65M | $635.34M | $461.94M |
Cash & Equivalents | $587.00M | $349.77M | $348.31M | $1.41B |
Free Cash Flow OCF − CapEx | $633.95M | $368.04M | $294.58M | $96.11M |
Shares Outstanding | 926.99M | 909.23M | 902.74M | 912.14M |